Sell Rating on Moderna Due to Uncertainties and Competitive Pressures
Leerink Partners analyst Mani Foroohar has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Invest with ...
Moderna stock rises following RFK Jr's comments
Shares of Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) climbed 5.4% mid-day Tuesday as remarks by RFK Jr, who clarified his stance as not being anti-vaccine or anti-industry, appeared to bolster investor ...
How Is The Market Feeling About Moderna?
Moderna's MRNA +3.99% Get Free Report short percent of float has risen 13.6% since its last report. The company recently ...
cidrap.umn23h
HHS awards $590 million to Moderna to develop mRNA vaccines against pandemic flu threats
On one of the final days of the Biden Administration, the US Department of Health and Human Services (HHS) announced $590 million in support for Moderna to speed the development of mRNA vaccines ...